CARDIFF ONCOLOGY, INC. Deferred Rent Credit
CARDIFF ONCOLOGY, INC. (CRDF) had Deferred Rent Credit of $1.86 million as of 2016-04-04, per its 10-Q filed 2016-11-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRentCredit · last filed 2016-11-09
- 2016-04-04: Deferred Rent Credit $1.86M.
| Period end | Deferred Rent Credit |
|---|---|
| 2016-04-04 | $1.86M 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |